Skip to main content
British Journal of Cancer logoLink to British Journal of Cancer
. 1989 Jul;60(1):36–40. doi: 10.1038/bjc.1989.215

Cinnarizine and flunarizine improve the tumour radiosensitisation induced by erythrocyte transfusion in anaemic mice.

P J Wood 1, D G Hirst 1
PMCID: PMC2247332  PMID: 2803913

Abstract

The ability of the calcium antagonists, cinnarizine and flunarizine, to enhance the radiosensitisation produced by the administration of an erythrocyte transfusion to anaemic, RIF-1 or SCCVII/St tumour bearing mice was determined. Erythrocyte transfusion alone increased radiation cell killing 10-fold in the RIF-1 tumour when given 0-4 h before X-rays. In contrast, the SCCVII/St showed only a 4-fold increase in sensitivity, apparent when erythrocytes were given 2-6 h before irradiation. The administration of 50 mg kg-1 cinnarizine or flunarizine to anaemic mice followed by erythrocyte transfusion 0 h before X-rays produced the same level of cell survival for both tumours, a 20-fold increase in cell killing for cinnarizine, and a 30-40-fold effect for flunarizine, even though at this time interval, the erythrocyte transfusion alone did not sensitise the SCCVII/St tumour to X-rays. Further investigations indicated, however, that the erythrocyte transfusion was necessary to achieve the sensitisation with the calcium antagonists, since giving flunarizine to anaemic mice alone only achieved a 4-fold increase in radiation cell killing. In addition, flunarizine given with erythrocyte transfusion 4 h before X-rays, in SCCVII/St, the optimal time for radiosensitisation in this tumour, did not further increase the level of cell killing achieved by flunarizine plus erythrocyte transfusion 0 h before X-rays.

Full text

PDF
36

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brown J. M. Evidence for acutely hypoxic cells in mouse tumours, and a possible mechanism of reoxygenation. Br J Radiol. 1979 Aug;52(620):650–656. doi: 10.1259/0007-1285-52-620-650. [DOI] [PubMed] [Google Scholar]
  2. Bush R. S., Jenkin R. D., Allt W. E., Beale F. A., Bean H., Dembo A. J., Pringle J. F. Definitive evidence for hypoxic cells influencing cure in cancer therapy. Br J Cancer Suppl. 1978 Jun;3:302–306. [PMC free article] [PubMed] [Google Scholar]
  3. Chaplin D. J., Durand R. E., Olive P. L. Acute hypoxia in tumors: implications for modifiers of radiation effects. Int J Radiat Oncol Biol Phys. 1986 Aug;12(8):1279–1282. doi: 10.1016/0360-3016(86)90153-7. [DOI] [PubMed] [Google Scholar]
  4. De Cree J., De Cock W., Geukens H., De Clerck F., Beerens M., Verhaegen H. The rheological effects of cinnarizine and flunarizine in normal and pathologic conditions. Angiology. 1979 Aug;30(8):505–515. doi: 10.1177/000331977903000801. [DOI] [PubMed] [Google Scholar]
  5. Hirst D. G., Brown J. M., Hazlehurst J. L. Enhancement of CCNU cytotoxicity by misonidazole: possible therapeutic gain. Br J Cancer. 1982 Jul;46(1):109–116. doi: 10.1038/bjc.1982.172. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Hirst D. G., Hazlehurst J. L., Brown J. M. The effect of alterations in haematocrit on tumour sensitivity to X-rays. Int J Radiat Biol Relat Stud Phys Chem Med. 1984 Oct;46(4):345–354. doi: 10.1080/09553008414551521. [DOI] [PubMed] [Google Scholar]
  7. Hirst D. G., Wood P. J. The adaptive response of mouse tumours to anaemia and retransfusion. Int J Radiat Biol Relat Stud Phys Chem Med. 1987 Apr;51(4):597–609. doi: 10.1080/09553008414552131. [DOI] [PubMed] [Google Scholar]
  8. Jirtle R. L. Chemical modification of tumour blood flow. Int J Hyperthermia. 1988 Jul-Aug;4(4):355–371. doi: 10.3109/02656738809016490. [DOI] [PubMed] [Google Scholar]
  9. Kaelin W. G., Jr, Shrivastav S., Jirtle R. L. Blood flow to primary tumors and lymph node metastases in SMT-2A tumor-bearing rats following intravenous flunarizine. Cancer Res. 1984 Mar;44(3):896–899. [PubMed] [Google Scholar]
  10. Kaelin W. G., Jr, Shrivastav S., Shand D. G., Jirtle R. L. Effect of verapamil on malignant tissue blood flow in SMT-2A tumor-bearing rats. Cancer Res. 1982 Oct;42(10):3944–3949. [PubMed] [Google Scholar]
  11. Overgaard J., Hansen H. S., Jørgensen K., Hjelm Hansen M. Primary radiotherapy of larynx and pharynx carcinoma--an analysis of some factors influencing local control and survival. Int J Radiat Oncol Biol Phys. 1986 Apr;12(4):515–521. doi: 10.1016/0360-3016(86)90058-1. [DOI] [PubMed] [Google Scholar]
  12. Twentyman P. R., Brown J. M., Gray J. W., Franko A. J., Scoles M. A., Kallman R. F. A new mouse tumor model system (RIF-1) for comparison of end-point studies. J Natl Cancer Inst. 1980 Mar;64(3):595–604. [PubMed] [Google Scholar]
  13. Wood P. J., Hirst D. G. Cinnarizine and flunarizine as radiation sensitisers in two murine tumours. Br J Cancer. 1988 Dec;58(6):742–745. doi: 10.1038/bjc.1988.301. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES